Prostate cancer is one of the most common cancers affecting men. In its early stages, it may not cause any noticeable symptoms. A simple blood test called the prostate-specific antigen (PSA) test can help identify men who may require further evaluation. However, PSA testing is not necessary for every man at every age.
What is a prostate-specific antigen test?
PSA is a protein produced by the prostate gland. A small amount is normally present in the blood. An elevated PSA level may be associated with prostate cancer, but it does not confirm cancer by itself.
PSA can also rise because of non-cancerous prostate enlargement, urinary infection, prostatitis, recent urinary instrumentation or ejaculation. Therefore, the result must always be interpreted along with the patient’s age, prostate size, symptoms, family history, examination findings and previous PSA values.
Who should consider PSA testing?
Current European Association of Urology recommendations support informed, risk-based PSA testing for men who have a life expectancy of at least 15 years. Testing may be discussed from:
- 50 years of age: For men at average risk
- 45 years of age: For men with a family history of prostate cancer, particularly when a relative was diagnosed before 60 years of age
- 45 years of age: For men of African ancestry, who may have a higher risk of developing prostate cancer
- 40 years of age: For men known to carry a BRCA2 gene mutation
Men with several relatives affected by prostate, breast, ovarian or pancreatic cancer should inform their doctor, as genetic counselling or earlier assessment may be appropriate.
Those individuals with urinary symptoms, an abnormal prostate examination, blood in the urine, unexplained weight loss or persistent bone pain should consult a urologist irrespective of their age. In these situations, PSA may be used as part of a diagnostic evaluation rather than routine screening.
Does PSA need to be tested every year?
Not necessarily. The interval depends on the initial PSA level and the individual’s overall risk. Some higher-risk men may need repeat testing approximately every two years, while men with a low baseline PSA may safely wait much longer. Routine PSA screening is generally unlikely to benefit men with poor overall health or a life expectancy below 15 years.
What happens if PSA is elevated?
An elevated PSA does not automatically mean prostate cancer or that a biopsy is immediately required. In an otherwise asymptomatic man with a PSA between 3 and 10 ng/mL, the test is often repeated before further investigations. The urologist may then advise a digital rectal examination, prostate MRI, PSA density, a risk calculator or selected additional biomarker tests. If suspicion remains significant, a prostate biopsy may be recommended.
PSA testing works best when it is a shared and informed decision—not a blanket test for everyone. Discussing your age, health, family history and individual risk with a urologist can help determine when to start testing and how often it should be repeated.
(The author is an associate consultant in urology at Manipal Hospital, Bhubaneswar)
The opinions expressed in this article are those of the author and do not purport to reflect the opinions or views of THE WEEK.